Elizabeth Kwo sold $97k of KMTS
director at KESTRA MEDICAL TECHNOLOGIES, LTD.. 4,010 shares at an average of $24.26, traded Sep 21, 2026, filed Sep 23, 2026.
Score components
- +15RoleDirector
- +10Trade size$97k at market
- +5Share of holdings soldSold 22% of holdings
- +15Cluster6 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-399696, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 21, 2026 | SOpen-market sale Common Shares | -4,010 | $24.26 | $97k | 14,116 | 19 d ago |
Related signals
Other insiders at KESTRA MEDICAL TECHNOLOGIES, LTD. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | KESTRA MEDICAL TECHNOLOGIES, LTD. | Raymond W Cohen director | $98k 3,330 shares | -6% | |
| 51Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Conor Hanley director | $144k 5,694 shares | -48% | |
| 50Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Jeffrey Lawrence Schwartz director, owner | $98k 3,890 shares | -36% | |
| 40Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Mary Kay Ladone director | $98k 3,908 shares | -9% | |
| 48Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Kevin C Reilly director | $74k 2,932 shares | -35% | |
| 65Notable | KESTRA MEDICAL TECHNOLOGIES, LTD. | Alfred J Ford Jr Chief Commercial Officer | $340k 20,000 shares | +68% | |
| 56Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Traci S Umberger See Remarks | $230k 13,500 shares | +11% | |
| 64Notable | KESTRA MEDICAL TECHNOLOGIES, LTD. | Raymond W Cohen director | $289k 17,000 shares | +131% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.